Yash Optics & Lens Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.4%
- Company has a healthy return on capital (ROCE) of 34.4%
- Company comfortably covers its interest (11.6x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.71x)
- Operating cash flow has been negative in recent years
- Working capital days have increased from 176 to 524 days
- Free cash flow has been persistently negative
- Operating margins have contracted to 29.1% from 34.7%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| LENSKART | 681.75 | 180.93 | 118577.20 | 0.00 | 2284.30 | 3634.35 | 27141.80 | 1332.69 | 12.55 | 21.70 |
| POLYMED | 1737.35 | 55.89 | 17610.03 | 0.20 | 85.27 | -8.39 | 525.38 | 30.30 | 14.05 | 24.11 |
| MOLBIO | 1441.60 | 99.72 | 16613.00 | 0.00 | 527.44 | — | 4083.76 | — | 19.79 | 24.63 |
| 3BBLACKBIO | 1423.95 | 22.01 | 1222.13 | 0.35 | 8.98 | -28.99 | 33.49 | 50.59 | 26.03 | 25.45 |
| LAXMIDENTL | 201.95 | 35.98 | 1111.32 | 0.00 | 10.32 | 23.83 | 74.70 | 16.13 | 24.96 | 20.26 |
| YASHOPTICS | 121.85 | 33.35 | 301.77 | 0.41 | — | — | — | — | 17.76 | — |
| GKB | 63.70 | 9.90 | 32.11 | 0.00 | 1.85 | 387.99 | 33.04 | 2.26 | 8.82 | 7.97 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 15 | 30 | 40 | 41 | 43 | |
| 13 | 20 | 27 | 27 | 31 | |
| Operating Profit | 2 | 10 | 12 | 15 | 13 |
| OPM % | 13.74% | 34.35% | 31.42% | 35.52% | 29.12% |
| 0 | 0 | 0 | 0 | 3 | |
| Interest | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 1 |
| Profit before Tax | 1 | 9 | 11 | 12 | 13 |
| Tax % | 28.46% | 25.59% | 26.02% | 25.55% | 26.18% |
| Net Profit | 1 | 7 | 8 | 9 | 10 |
| EPS | 0.60 | 3.85 | 8028.03 | 4.96 | 3.87 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 13%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 12%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -5%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 44%
- 3 Years:
- 35%
- Last Year:
- 16%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0 | 0 | 0 | 18 | 25 |
| 4 | 11 | 19 | 12 | 66 | |
| 6 | 4 | 11 | 19 | 15 | |
| Trade Payables | 2 | 8 | 3 | 4 | 5 |
| 0 | 1 | 1 | 8 | 2 | |
| Total Liabilities | 12 | 24 | 34 | 61 | 112 |
| 0 | 4 | 8 | 19 | 30 | |
| Capital Work in Progress | 0 | 0 | 0 | 6 | 3 |
| 6 | 11 | 16 | 20 | 22 | |
| 0 | 0 | 0 | 12 | 16 | |
| Cash & Bank | 1 | 1 | 1 | 1 | 32 |
| 5 | 8 | 10 | 2 | 10 | |
| Total Assets | 12 | 24 | 34 | 61 | 112 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0 | 10 | -9 | -12 | 6 | |
| Cash from Investing | -0 | -5 | -8 | -19 | -37 |
| Cash from Financing | 0 | -2 | 10 | 31 | 31 |
| 0 | 0 | -11 | 0 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for YASHOPTICS
Loading news…
AI Stock Analyst
Yash Optics & Lens Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account